Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

245
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
245
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K
Stem Cell Culture01:17

Stem Cell Culture

6.0K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
6.0K
iPS Cell Differentiation01:22

iPS Cell Differentiation

3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First-in-Human Study of MDG1011, a TCR-T Therapy Directed Against HLA-A*02:01-Restricted PRAME Antigen for High-Risk Myeloid and Lymphoid Neoplasms.

Cancers·2025
Same author

WT1 and PRAME RNA-loaded dendritic cell vaccine as maintenance therapy in de novo AML after intensive induction chemotherapy.

Leukemia·2023
Same author

MicroRNA cargo of extracellular vesicles released by skeletal muscle fibro-adipogenic progenitor cells is significantly altered with disuse atrophy and IL-1β deficiency.

Physiological genomics·2022
Same author

Novel low shear 3D bioreactor for high purity mesenchymal stem cell production.

PloS one·2021
Same author

Enhancer of zeste homolog 2 (EZH2) regulates adipocyte lipid metabolism independent of adipogenic differentiation: Role of apolipoprotein E.

The Journal of biological chemistry·2019
Same author

Convergences of Life Sciences and Engineering in Understanding and Treating Heart Failure.

Circulation research·2019

Related Experiment Video

Updated: Jan 12, 2026

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment
08:24

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Published on: May 25, 2020

7.4K

Stem cell therapy for heart failure: the science and current progress.

M Ian Phillips1, Yao Liang Tang, Kai Pinkernell

  • 1Keck Graduate Institute, Stem Cell Labs, 535 Watson Drive, Claremont, CA 91711, USA. ian_phillips@kgi.edu

Future Cardiology
|October 7, 2009
PubMed
Summary
This summary is machine-generated.

Stem cell therapy shows promise for treating post-ischemic heart disease by regenerating damaged heart cells. Ongoing research explores various stem cell types and genetic modifications to improve survival and cardiac repair.

More Related Videos

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

8.2K
Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart
11:45

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

7.0K

Related Experiment Videos

Last Updated: Jan 12, 2026

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment
08:24

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Published on: May 25, 2020

7.4K
Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

8.2K
Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart
11:45

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

7.0K

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Research
  • Stem Cell Biology

Background:

  • Limited treatments exist for post-ischemic heart disease, lacking methods to regenerate damaged cardiac tissue.
  • Early cell therapy trials, including those with myoblasts and bone marrow-derived stem cells, suggest potential improvements in cardiac function.
  • Significant interest exists in stem cell therapy for cardiac repair and regeneration.

Purpose of the Study:

  • To review current advancements and explore various stem cell types for treating post-ischemic heart disease.
  • To discuss the potential advantages of different adult stem cell sources, including adipose-derived, cardiac-derived, and mesenchymal stem cells.
  • To highlight emerging strategies like induced pluripotent stem cells and genetic modification for enhanced stem cell efficacy in cardiac regeneration.

Main Methods:

  • Review of existing literature on cell therapy for cardiac disease.
  • Exploration of different adult stem cell types: autologous adipose-derived stem cells, cardiac-derived stem cells, human umbilical cord blood cells, allogeneic adult mesenchymal stem cells, and human embryonic stem cells.
  • Discussion of novel approaches including induced pluripotent stem cells and genetic modification (e.g., with heme oxygenase, Akt).

Main Results:

  • Various stem cell types demonstrate potential for improving cardiac performance and clinical outcomes in post-ischemic heart disease.
  • Adipose-derived stem cells offer multilineage potential and ease of acquisition; cardiac-derived stem cells are suited for cardiac niche engraftment.
  • Induced pluripotent stem cells present a new avenue for generating autologous pluripotent stem cells; genetic modification may enhance stem cell survival in hypoxic conditions.

Conclusions:

  • Stem cell therapy is a rapidly advancing field for cardiac disease, with diverse cell sources and strategies under investigation.
  • The efficacy of stem cells may depend on factors like homing signals and secreted hormones that stimulate cardiac regrowth.
  • Further large-scale clinical trials are necessary to validate the long-term benefits of stem cell therapy in cardiac regeneration.